We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Fastest Earnings Preview for Monsanto (MON) Stock
Read MoreHide Full Article
Today’s video takes a super quick look at shares of Monsanto heading into their earnings release. The company doesn’t exactly have a great track record when it comes to earnings, as it has missed estimates in three of the last four quarters, including both of the last two.
Earnings estimates have also been sluggish for the stock, as the consensus estimate has been sliding over the past few months, and is back down to 2014 levels. However, the stock has moved out of Zacks Rank sell territory, and it is at least a hold now. Additionally, the company is in a great industry which is currently ranked in the top 10% overall so at least the overall space is promising, giving a very mixed picture overall.
But no matter how you feel about this name, it could be a company to avoid in the near term. Buyout rumors look likely to dominate the stock, and could override any news on the earnings front, no matter if it is another miss or a beat. The company received an offer from Bayer at about $128/share, but the stock is stuck in the low $100s thanks to antitrust concerns. As we learn more about this, it will likely override any news on the earnings front, at least over the long term.
Monsanto reports before the bell on October 5th and we are looking for a loss of two cents per share from the company. Make sure to watch the video for a quick guide to MON heading into the release, but if you want some insights on how to trade stocks ahead of earnings reports, check out our podcast on the topic below:
Due to inactivity, you will be signed out in approximately:
Image: Bigstock
The Fastest Earnings Preview for Monsanto (MON) Stock
Today’s video takes a super quick look at shares of Monsanto heading into their earnings release. The company doesn’t exactly have a great track record when it comes to earnings, as it has missed estimates in three of the last four quarters, including both of the last two.
Earnings estimates have also been sluggish for the stock, as the consensus estimate has been sliding over the past few months, and is back down to 2014 levels. However, the stock has moved out of Zacks Rank sell territory, and it is at least a hold now. Additionally, the company is in a great industry which is currently ranked in the top 10% overall so at least the overall space is promising, giving a very mixed picture overall.
MONSANTO CO-NEW Price, Consensus and EPS Surprise
MONSANTO CO-NEW Price, Consensus and EPS Surprise | MONSANTO CO-NEW Quote
But no matter how you feel about this name, it could be a company to avoid in the near term. Buyout rumors look likely to dominate the stock, and could override any news on the earnings front, no matter if it is another miss or a beat. The company received an offer from Bayer at about $128/share, but the stock is stuck in the low $100s thanks to antitrust concerns. As we learn more about this, it will likely override any news on the earnings front, at least over the long term.
Monsanto reports before the bell on October 5th and we are looking for a loss of two cents per share from the company. Make sure to watch the video for a quick guide to MON heading into the release, but if you want some insights on how to trade stocks ahead of earnings reports, check out our podcast on the topic below: